Neuro-oncology
Na?/K?-ATPase �2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells.
Neuro-oncology
TMOD-28. NEW APPROACHES FOR ELUCIDATING MEDULLOBLASTOMA DEVELOPMENT VIA HINDBRAIN BLASTOCYST COMPLEMENTATION.
Neuro-oncology
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence.
Neuro-oncology
Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop.
Neuro-oncology